104 related articles for article (PubMed ID: 9059845)
1. Adenosine kinase inhibition protects brain against transient focal ischemia in rats.
Jiang N; Kowaluk EA; Lee CH; Mazdiyasni H; Chopp M
Eur J Pharmacol; 1997 Feb; 320(2-3):131-7. PubMed ID: 9059845
[TBL] [Abstract][Full Text] [Related]
2. An adenosine kinase inhibitor attenuates tactile allodynia in a rat model of diabetic neuropathic pain.
Lynch JJ; Jarvis MF; Kowaluk EA
Eur J Pharmacol; 1999 Jan; 364(2-3):141-6. PubMed ID: 9932716
[TBL] [Abstract][Full Text] [Related]
3. Delayed treatment with an adenosine kinase inhibitor, GP683, attenuates infarct size in rats with temporary middle cerebral artery occlusion.
Tatlisumak T; Takano K; Carano RA; Miller LP; Foster AC; Fisher M
Stroke; 1998 Sep; 29(9):1952-8. PubMed ID: 9731623
[TBL] [Abstract][Full Text] [Related]
4. Site and event specific increase of striatal adenosine release by adenosine kinase inhibition in rats.
Britton DR; Mikusa J; Lee CH; Jarvis MF; Williams M; Kowaluk EA
Neurosci Lett; 1999 May; 266(2):93-6. PubMed ID: 10353335
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the effects of adenosine kinase inhibitors on acute thermal nociception in mice.
Kowaluk EA; Kohlhaas KL; Bannon A; Gunther K; Lynch JJ; Jarvis MF
Pharmacol Biochem Behav; 1999 May; 63(1):83-91. PubMed ID: 10340527
[TBL] [Abstract][Full Text] [Related]
6. Pre- and peristroke treatment with the adenosine kinase inhibitor, 5'-deoxyiodotubercidin, significantly reduces infarct volume after temporary occlusion of the middle cerebral artery in rats.
Miller LP; Jelovich LA; Yao L; DaRe J; Ugarkar B; Foster AC
Neurosci Lett; 1996 Dec; 220(2):73-6. PubMed ID: 8981476
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive limb remote ischemic preconditioning contributes neuroprotective effects via activation of adenosine A1 receptor and redox status after transient focal cerebral ischemia in rats.
Hu S; Dong H; Zhang H; Wang S; Hou L; Chen S; Zhang J; Xiong L
Brain Res; 2012 Jun; 1459():81-90. PubMed ID: 22560096
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effects of erythropoietin pretreatment in a rodent model of transient middle cerebral artery occlusion.
Ratilal BO; Arroja MM; Rocha JP; Fernandes AM; Barateiro AP; Brites DM; Pinto RM; Sepodes BM; Mota-Filipe HD
J Neurosurg; 2014 Jul; 121(1):55-62. PubMed ID: 24702327
[TBL] [Abstract][Full Text] [Related]
9. Calcineurin inhibitors FK506 and SDZ ASM 981 alleviate the outcome of focal cerebral ischemic/reperfusion injury.
Bochelen D; Rudin M; Sauter A
J Pharmacol Exp Ther; 1999 Feb; 288(2):653-9. PubMed ID: 9918571
[TBL] [Abstract][Full Text] [Related]
10. The adenosine kinase inhibitor, 5-iodotubercidin, is not protective against cerebral ischemic injury in the gerbil.
Phillis JW; Smith-Barbour M
Life Sci; 1993; 53(6):497-502. PubMed ID: 8341136
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effect of SolCD39, a novel platelet aggregation inhibitor, on transient middle cerebral artery occlusion in rats.
Belayev L; Khoutorova L; Deisher TA; Belayev A; Busto R; Zhang Y; Zhao W; Ginsberg MD
Stroke; 2003 Mar; 34(3):758-63. PubMed ID: 12624304
[TBL] [Abstract][Full Text] [Related]
12. D-JNKi, a peptide inhibitor of c-Jun N-terminal kinase, promotes functional recovery after transient focal cerebral ischemia in rats.
Esneault E; Castagne V; Moser P; Bonny C; Bernaudin M
Neuroscience; 2008 Mar; 152(2):308-20. PubMed ID: 18262367
[TBL] [Abstract][Full Text] [Related]
13. [Protective effect of cyclopentyladenosine in a minimally invasive model of acute cerebral focal ischemia in rats].
Sufianova GZ; Usov LA; Sufianov AA; Shapkin AG; Raevskaia LIu
Eksp Klin Farmakol; 2002; 65(1):24-6. PubMed ID: 12025778
[TBL] [Abstract][Full Text] [Related]
14. Post-treatment of transient focal cerebral ischemia in rats with the novel cerebrovascular-selective Ca2+ channel antagonist (+/-)-(E)-1-(3-fluoro-6,11-dihydrodibenz[b,e]-oxepine-11-yl)-4-(3-pheny l-2-propenyl)-piperazine dimaleate.
Minato H; Kikuta C; Masuda Y; Fujitani B; Hosoki K
Arzneimittelforschung; 1997 Jul; 47(7):799-802. PubMed ID: 9272234
[TBL] [Abstract][Full Text] [Related]
15. Wide therapeutic time window for nimesulide neuroprotection in a model of transient focal cerebral ischemia in the rat.
Candelario-Jalil E; González-Falcón A; García-Cabrera M; León OS; Fiebich BL
Brain Res; 2004 May; 1007(1-2):98-108. PubMed ID: 15064140
[TBL] [Abstract][Full Text] [Related]
16. The phospholipase A2 inhibitor, quinacrine, reduces infarct size in rats after transient middle cerebral artery occlusion.
Estevez AY; Phillis JW
Brain Res; 1997 Mar; 752(1-2):203-8. PubMed ID: 9106458
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotection by 2-h postischemia administration of two free radical scavengers, alpha-phenyl-n-tert-butyl-nitrone (PBN) and N-tert-butyl-(2-sulfophenyl)-nitrone (S-PBN), in rats subjected to focal embolic cerebral ischemia.
Yang Y; Li Q; Shuaib A
Exp Neurol; 2000 May; 163(1):39-45. PubMed ID: 10785442
[TBL] [Abstract][Full Text] [Related]
18. Effects of ifenprodil, a polyamine site NMDA receptor antagonist, on reperfusion injury after transient focal cerebral ischemia.
Doğan A; Rao AM; Başkaya MK; Rao VL; Rastl J; Donaldson D; Dempsey RJ
J Neurosurg; 1997 Dec; 87(6):921-6. PubMed ID: 9384405
[TBL] [Abstract][Full Text] [Related]
19. Emulsified Isoflurane Protects Against Transient Focal Cerebral Ischemia Injury in Rats via the PI3K/Akt Signaling Pathway.
Zhang H; Xiong X; Liu J; Gu L; Li F; Wan Y; Xu S
Anesth Analg; 2016 May; 122(5):1377-84. PubMed ID: 26859875
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotection by LY341122, a novel inhibitor of lipid peroxidation, against focal ischemic brain damage in rats.
Huh PW; Belayev L; Zhao W; Clemens JA; Panetta JA; Busto R; Ginsberg MD
Eur J Pharmacol; 2000 Feb; 389(1):79-88. PubMed ID: 10686299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
